ArticleBioactive materials2026
Skin-mimetic bilayer hydrogel normalizes diabetic wound healing by orchestrating inflammatory cell dynamics: An early intervention strategy.
Article in Bioactive materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Salidroside-loaded stem cell-derived artificial nanovesicles in hydrogel microneedles alleviate inflammation and enhance diabetic wound regeneration.Materials today. Bio · 2026Article
- Mild Heat Stimulating and Microenvironment Reprogramming Hydrogel for Accelerating Diabetic Wound Healing.Gels (Basel, Switzerland) · 2026Article
- Mechanism of Platelet-Rich Plasma in Promoting Diabetic Wound Healing via the PI3K/AKT Signaling Pathway to Regulate Collagen Synthesis and Angiogenesis.Journal of diabetes research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetic ulcers, characterized by persistent chronic inflammation and impaired healing, pose a significant clinical challenge. Inspired by the physiological healing process observed in healthy wounds, we develop an early intervention strategy by the spatiotemporal modulation of inflammatory cell dynamics to restore inflammation homeostasis in diabetic wounds. To achieve this, a skin-mimetic bilayer hydrogel that mimics the layered structure, composition, and pore size distribution of human skin is developed to allow for the sequential release of neuropeptide substance P and interleukin-10. Our findings demonstrate that this bilayer hydrogel achieves layer-specific pore size distributions and seamless interlayer integration through spontaneous dynamic crosslinking, along with clinically relevant multifunctionality. Notably, it enables rapid release of substance P from its loose bottom layer to enhance neutrophil recruitment within the first day and promote pro-inflammatory macrophage infiltration during the early inflammatory phase. Subsequently, the dense top layer enables delayed and sustained release of interleukin-10, which induces M2c macrophage polarization to facilitate inflammation resolution and support scarless wound closure. Overall, this study provides an effective early intervention strategy to reinstate the physiological healing process in diabetic wounds, thereby preventing chronic ulcer progression and non-healing outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.